IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway

European Journal of Immunology

Volumn 30, Issue 6, 2000, Pages 1683-1690

  Joss, Andrea ^a   Akdis, Mübeccel ^a   Faith, Alexander ^a   Blaser, Kurt ^a   Akdis, Cezmi A ^a  

^a SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

Author keywords

CD28; IL 10; Phosphatidylinositol 3 kinase; Suppression; T lymphocyte

Indexed keywords

CD28 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MONOCLONAL ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; SUPERANTIGEN;

ARTICLE; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIGENS, CD28; ANTIGENS, CD3; CYTOKINES; ENTEROTOXINS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-2; MICE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUPERANTIGENS; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS; TYROSINE;

EID: 0034039840     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200006)30:6<1683::AID-IMMU1683>3.0.CO;2-A     Document Type: Article

References (47)

1. Schwartz, R. H., T cell clonal anergy. Curr. Opin. Immunol. 1997. 9: 351-357.
2. Linsley, P. S., Clark, E. A., and Ledbetter, J.A., T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc. Natl. Acad. Sci. USA 1990. 87: 5031-5035.
3. Linsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K. and Ledbetter, J. A., Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin2 mRNA accumulation. J. Exp. Med. 1991. 173: 721-730.
4. Lenschow, D. J., Zeng, Y., Thistlethwaite, R. J., Montag, A., Brady, W., Gibson, M. G., Linsley, P. S. and Bluestone, J. A., Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 1992. 257: 789-795.
5. Tan, P., Anasetti, C., Hansen, J. A., Melrose, J., Brunvand, M., Bradshaw, J., Ledbetter, J. A. and Linsley, P. S. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.J. Exp. Med. 1993. 177: 165-173.
6. Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H. and Allison, J. P., CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992. 356: 607-609.
7. Pagès, F., Ragueneau, M, Rottapel, R., Truneh, A., Nunes, J., Imbert, J. and Olive, D., Binding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signaling. Nature 1994. 369: 327-329.
8. Prasad, K. V., Cai, Y-C., Raab, M., Duckworth, B., Cantley, L., Shoelson, S. and Rudd, C. E., T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif. Proc. Natl. Acad. Sci. USA 1994. 91: 2834-2838.
9. Ward, S. G., June, C. H. and Olive, D., Pl 3-kinase: a pivotal pathway in T-cell activation?. Immunol. Today 1996. 17: 187-197.
10. Fiorentino, D. F., Bond, M. W. and Mosmann, T. R., Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989. 170: 2081-2095.
11. de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G. and Vries, J. E., Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulalory role of IL-10 produced by monocytes. J. Exp. Med. 1991. 174: 1209-1220.
12. Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M. and O'Garra, A., IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 1991: 147: 3815-3822.
13. Hsu, D.-H., Moore, K. W. and Spits, H., Differential effects of IL-4 and IL-10 on IL-2-induced IFN-gamma synthesis and lymphokine-activated killer activity. Int. Immunol. 1992. 4: 563-569.
14. + T cell clones and peripheral blood T cells. J. Immunol. 1992. 149: 2378-2384.
15. Bacchetta, R., Bigler, M., Touraine, J.-L., Parkman, R., Tovo, P.-A., Abrams, J., de Waal Malefyt, R., de Vries, J. E. and Roncarolo, M.-G., High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J. Exp. Med. 1994. 179: 493-502.
16. Becker, J. C., Czerny, C. and Bröcker, E.-B. Maintenance of clonal anergy by endogeneously produced IL-10. Int. Immunol. 1994. 6: 1605-1612.
17. Akdis, C. A., Blesken, T., Akdis, M., Wüthrich, B. and Blaser, K., Role of interleukin 10 in specific immunotherapy. J. Clin. Invest. 1998. 102: 98-106.
18. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997. 389: 737-742.
19. Del Prete, G., de Carli, M., Almerigogna, F., Giudizi, M. G., Biagiotti, R. and Romagnani, S., Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 1993. 150: 363-360.
20. de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M.-G., te Velde, A., Figdor, C. G., Johnson, K. E., Kastelein, R., Yssel, H. and de Vries, J. E., Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 1991. 174: 915-924.
21. Kawamura, T. and Furue, M., Comparative analysis of B7-1 and B7-2 expression in Langerhans cells: differential regulation by T helper type 1 and T helper type 2 cytokines. Eur. J. Immunol. 1995. 25: 1913-1917.
22. Mitra, R. S., Judge., T. A., Nestle, F. O., Turka, L. A. and Nickoloff, B. J., Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. J. Immunol. 1995. 154: 2668-2677.
23. Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W. and O'Garra, A., IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 1991. 146: 3444-3451.
24. Ding, L., Linsley, P. S., Huang, L. Y., Germain, R. N. and Shevach, E. M., IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 1993. 151: 1224-1234.
25. Scheffold, A., Assenmacher, M., Reiners-Schramm., L., Lauster, R. and Radbruch, A., High-sensitivity immunofluorescence for detection of the pro- and anti-inflammatory cytokines gamma interferon and interleukin-10 on the surface of cytokine-secreting cells. Nature Med. 2000. : 107-110.
26. Parijs, L. V. and Abbas, A. K., Homeostasis and self-tolerance the immune system: turning lymphocytes off. Science 1998. 280: 243-248.
27. Essery, ., Feldman, M. and Lamb, J. R., Interleukin-2 can prevent and reverse antigen-induced unresponsiveness in cloned human T lymphocytes. Immunology 1988. 64: 413-417.
28. Ghiotto-Ragueneau, M., Battifora, M., Truneh, A., Waterfield, M. D. and Olive, D., Comparison of CD28-B7.1 and B7.2 functional interaction in resting human T cells: phosphatidylinositol 3-kinase association to CD28 and cytokine production. Eur. J. Immunol. 1996. 26: 34-41.
29. Viola, A. and Lanzavecchia, A., T cell activation determined by T cell receptor number and tunable thresholds. Science 1996. 273: 104-106.
30. Jenkins, M. K. and Schwartz, R., Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 1987. 165: 302-319.
31. Lamb, J.R., Skidmore, N., Green, N., Chiller, J. M. and Feldman, M., Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J. Exp. Med. 1983. 157: 1434-1447.
32. Beverly, B., Kang, S.-M., Lenardo, M. J. and Schwartz, R. H., Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int. Immunol. 1992. 4: 661-671.
33. Müller, D. L., Chiodetti, L., Bacon, P. A. and Schwartz, R. H., Clonal anergy blocks the response to IL-4, as well as the production of IL-2 in dual-producing helper T cell clones. J. Immunol 1991. 147: 4118-4125.
34. 2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J. Clin. Invest. 1996. 98: 1676-1683.
35. Faith, A., Akdis, C. A., Akdis, M., Joss, A., Wymann, D. and Blaser, K., An altered peptide ligand specifically inhibits Th2 cytokine synthesis by abrogating TCR signaling. J. Immunol. 1999. 162: 1836-1842.
36. Blay, J. Y., Burdin, N., Rousset, F., Lenoir, G., Biron, P., Philip, T., Banchereau, J. and Favrot, M. C., Serum interleukin-10 in non-Hodgkins' lymphoma: a prognostic factor. Blood 1993. 82: 2169-2174.
37. Akdis, C. A. and Blaser, K., IL-10 induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: Two key steps in specific immunotherapy. FASEB J. 1999. 13: 603-609.
38. Wang, R., Fang, Q., Zhang, L., Radvany, L., Sharma, A., Noben-Trauth, N., Mills, G. B. and Shi, Y., CD28 ligation prevents bacterial toxin-induced septic shock in mice by inducing IL-10 expression. J. Immunol. 1997. 158: 2856-2861.
39. Perrin, G. Q., Johnson, H. M. and Subramaniam, P. S., Mechanism of interleukin-10 inhibition of T-helper cell activation by superantigen at the level of the cell cycle. Blood 1999. 93: 208-216.
40. Finbloom, D. S. and Winestock, K. D., IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1α and STAT3 complexes in human T cells and monocytes. J. Immunol. 1995. 155: 1079-1090.
41. Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, R. J. R., Jenkin, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A. and Hilton, D. J., A family of cytokine-inducible inhibitors of signalling. Nature 1997. . 387: 917-921.
42. Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Misui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., Miyazaki, T., Leonor, N., Taniguchi, T., Fujita, T., Kanakura, Y., Komiya, S. and Yoshimura, A., A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997. 387: 921-924.
43. Linsley, P. S., Wallace, P. M., Johnson, J., Gibson, M. G., Greene, J. A. L., Ledbetter, J. A., Singh, C. and Tepper, M. A., Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 1992. 257: 792-795.
44. Lee, K.-M., Chuang, E., Griffin, M., Khattri, R., Hong, D. K., Zhang, W., Straus, D., Samelson, L. E., Thompson, C. B. and Bluestone, J. A., Molecular basis of T cell inactivation by CTLA-4. Science 1998. 282: 2263-2266.
45. Liu, Y., de Waal Malefyt, R., Briere, R, Parham, C., Bridon, J.-M., Banchereau, J., Moore, K. W. and Xu, J., The Epstein-Barr virus interleukin-10 (IL-10) homolog is a selective agonist with impaired binding to the IL-10 receptor. J. Immunol. 1997. 158: 604-613.
46. Akdis, M., Akdis, C. A., Weigl, L., Disch, R. and Blaser, K., Skin-homing, CLA+ memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern. J. Immunol. 1997. 159: 4611-4619.
47. + T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis. J. Immunol. 1999. 163: 466-475.